ArticleClinical research in cardiology : official journal of the German Cardiac Society2013
Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- Femoral Versus Nonfemoral Subclavian/Carotid Arterial Access Route for Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.Journal of the American Heart Association · 2020Pooled it
- Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters.Clinical research in cardiology : official journal of the German Cardiac Society · 2014Trial
- Transsubclavian versus transfemoral TAVR with self-expanding valves.Frontiers in cardiovascular medicine · 2026Article
- Comparison of Transfemoral versus Transsubclavian/Transaxillary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.International journal of cardiology. Heart & vasculature · 2022Review
- The Role of the Axillary Artery as a Second Access Choice in TAVI Procedures.Brazilian journal of cardiovascular surgery · 2021Review
- The Transaxillary ApproachFrontiers in cardiovascular medicine · 2021Article
- Comparison of outcomes following transfemoral versus trans-subclavian approach for transcatheter aortic valve Implantation: A meta-analysis.International journal of cardiology. Heart & vasculature · 2020Review
- Article
- A meta-analysis comparing transaxillary and transfemoral transcatheter aortic valve replacement.Journal of thoracic disease · 2019Article
- Supraclavicular Subclavian access for Sapien Transcatheter aortic valve replacement- a novel approach.Journal of cardiothoracic surgery · 2018Article
- Transcatheter Aortic Valve Implantation.Current atherosclerosis reports · 2016Review
- Preferential short cut or alternative route: the transaxillary access for transcatheter aortic valve implantation.Journal of thoracic disease · 2015Review
- Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2014.Clinical research in cardiology : official journal of the German Cardiac Society · 2014Article
- Worldwide TAVI registries: what have we learned?Clinical research in cardiology : official journal of the German Cardiac Society · 2014Review
- Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure.Clinical research in cardiology : official journal of the German Cardiac Society · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe retrospectively analysed our experience with the subclavian access transcatheter aortic valve implantation (TAVI) with the self-expandable CoreValve prosthesis and compared the results with transfemorally treated patients.
backgroundFor TAVI, a subclavian access is alternatively used when the femoral arteries are diseased or very small.
methodsBetween June 2007 and February 2011, 341 patients underwent CoreValve implantation in the German Heart Center, Munich through either transfemoral (n = 301) or subclavian (n = 40) approach. The subclavian approach was chosen where transfemoral approach was not possible.
resultsThere was no difference in baseline characteristics between the groups. There were no significant differences between groups for parameters potentially related to improved valve positioning (contrast medium, fluoroscopy time, implantation of a second valve, post-implantation balloon dilatation, valve dislocation, pacemaker implantation, aortic regurgitation), while the procedure duration was longer (105 ± 40 vs. 82 ± 33 min, p = 0.001). With the Kaplan-Meier estimate, survival was not different among groups. Strokes, myocardial ischaemia, and access vessel complications occurred in 2.5, 0, and 7.5 % (subclavian group) vs. 4.3, 2.0, 10.6 % (transfemoral group), ns.
conclusionsOur results demonstrate the safety of the subclavian access for TAVI and comparability with the transfemoral approach. With longer duration of the procedure and no significant advantages in clinical outcome, the subclavian access will have an indication for selected patients, while transfemoral TAVI should be considered first choice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.